| Financial Year |
March 31 2023 |
| Monetary Funds |
532,191,769.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,451,637.26 |
| Accounts Receivable |
40,560,808.79 |
| Advances to Suppliers |
2,176,830.11 |
| Other Receivables |
1,078,568.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,749,796.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,848,354.40 |
| Total Current Assets |
614,057,765.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,056,414.33 |
| Investment Properties |
2,900,939.86 |
| Fixed Assetes |
105,883,943.40 |
| Under-construction Projects |
798,185,867.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
427,822,009.06 |
| Intangible Assets |
6,439,943.28 |
| R&D expenses |
5,661,760.80 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
21,436.43 |
| Deferred Income Tax Assets |
3,930,968.07 |
| Other Non-Current Assets |
2,056,383.73 |
| Sub-Total of Non-Current Assets |
1,357,750,302.71 |
| Total Assets |
1,971,808,068.04 |
| Short-Term Loans |
68,695,526.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,563,000.00 |
| Accounts Payable |
163,542,918.03 |
| Accounts Received In Advance |
278,615.25 |
| Employee Compensation Payable |
1,453,924.52 |
| Taxes Payable |
16,858,328.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,082,552.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
111,140,971.08 |
| Other Current Liabilities |
44,716.98 |
| Sub-Total of Current Liabilities |
423,405,836.60 |
| Long-term Loans |
117,913,851.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
58,852,912.57 |
| Deferred Income Tax Liabilities |
34,278,801.74 |
| Other Non-Current Liabilities |
66,115,712.72 |
| Sub-Total of Non-Current Liabilities |
280,521,937.24 |
| Total Liabilities |
703,927,773.84 |
| Paid-In Capital(Or Share Stock) |
320,000,000.00 |
| Capital Surplus |
549,508,133.84 |
| Surplus Reserve |
85,111,063.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
313,792,231.91 |
| Minority Stockholder's Interest |
1,590,307.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,266,289,987.15 |
| Owner's Equity（Stockholder's Equity） |
1,267,880,294.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,971,808,068.04 |
